Merkel Cell Carcinoma Developing after Bone Marrow Transplantation

Sorry, there is no abstract. Read the first few lines of the text instead! Patients undergoing bone marrow transplantation for haematopoietic malignancies have an increased risk of developing secondary malignancies. It has been estimated that the incidence of secondary cancer is 4.2 times higher than of primary cancer in the general population. Potential risk factors associated with the development of secondary cancers in bone marrow recipients include the use of an alkylating agent in therapy, previous total-body irradiation, severe acute graft-versus-host disease (GVHD) from grade II to grade IV, treatment of acute GVHD with either antithymocyte globulin or CD3 receptor antibody, and possibly chronic GVHD [1]. Copyright © 2000 S. Karger AG, Basel